- Home
- AAP vs CPRX Comparison
AAP vs CPRX Comparison
Compare AAP & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAP | CPRX |
|---|---|---|
| Founded | 1929 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.4B |
| IPO Year | 2002 | 2006 |
Fundamental Metrics
Financial Performance| Metric | AAP | CPRX |
|---|---|---|
| Price | $52.40 | $31.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 1 |
| Target Price | ★ $53.50 | $35.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 05-21-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | ★ 113.01 | 28.24 |
| EPS | ★ 0.73 | 0.50 |
| Revenue | ★ $8,601,000,000.00 | $119,072,803.00 |
| Revenue This Year | $0.35 | $9.20 |
| Revenue Next Year | $2.51 | $10.51 |
| P/E Ratio | $71.58 | ★ $18.54 |
| Revenue Growth | N/A | ★ 16.39 |
| 52 Week Low | $37.89 | $19.05 |
| 52 Week High | $70.00 | $32.56 |
Technical Indicators
Market Signals| Indicator | AAP | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 73.05 |
| Support Level | $50.54 | $22.41 |
| Resistance Level | $53.82 | $32.56 |
| Average True Range (ATR) | 2.48 | 1.24 |
| MACD | -0.82 | 0.21 |
| Stochastic Oscillator | 17.89 | 78.79 |
Price Performance
Historical ComparisonAbout AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.